Global Financial Private Client, LLC Gilead Sciences, Inc. Transaction History
Global Financial Private Client, LLC
- $267 Billion
- Q2 2025
A detailed history of Global Financial Private Client, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Global Financial Private Client, LLC holds 7,826 shares of GILD stock, worth $888,877. This represents 0.33% of its overall portfolio holdings.
Number of Shares
7,826
Previous 7,521
4.06%
Holding current value
$888,877
Previous $843 Million
2.96%
% of portfolio
0.33%
Previous 0.32%
Shares
16 transactions
Others Institutions Holding GILD
# of Institutions
2,329Shares Held
1.02BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$13.7 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$13.6 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$6.72 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.26 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.26 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $142B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...